The Clinical, Epidemiological and Treatment Characteristics of Head and Neck Cancer Patients
1 other identifier
observational
100
1 country
1
Brief Summary
The aim of our study is to prospectively collect information regarding (1) the demographic, lifestyle-related and clinical characteristics of patients with head and neck cancer and (2) the waiting times to diagnosis and therapy, and the 1-, 3- and 5-year survival of patients. We plan to gain insight into the characteristics and pathways of head and neck cancer patients in Baranya County, which can in turn help to identify factors that lead to improved or worse disease outcomes. (Thus, these factors can subsequently eliminated or lessened to improve the outcome of head and neck cancer patients. )
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2021
CompletedFirst Submitted
Initial submission to the registry
March 31, 2022
CompletedFirst Posted
Study publicly available on registry
April 8, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2029
ExpectedApril 8, 2022
March 1, 2022
3 years
March 31, 2022
March 31, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Characterization of patient pathways
Initial symptoms, waiting times to diagnosis and treatment, type of healthcare provision
2021-2024
Lifestyle-related factors
The effects of demographic and lifestyle-related factors on clinical outcome(s) using follow-up data
2021-2026
Hard endpoint outcomes: Overall survival, time to metastasis, disease-free survival
Assessment of overall survival, time to metastasis, disease-free survival
2021-2029
Interventions
No intervention.
Eligibility Criteria
Patients 18 years or over with primary head-neck cancer (with morphology of squamocellular carcinoma, ICD codes: C00-C14, C32) and no previously documented cancer.
You may qualify if:
- Patients 18 years or over presenting with head and neck cancer (with morphology of squamocellular carcinoma), who are subsequently given one of the following ICD-10 codes: Malignant neoplasms of lip, oral cavity and pharynx (C00-C14), Malignant neoplasm of larynx (C32) and for whom this is their first cancer.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Pécs, Clinical Centre
Pécs, Baranya, 7623, Hungary
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 31, 2022
First Posted
April 8, 2022
Study Start
October 1, 2021
Primary Completion
October 1, 2024
Study Completion (Estimated)
October 1, 2029
Last Updated
April 8, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share